HGV: The identification, biology and prevalence of an orphan virus

Liver

Volumn 18, Issue 3, 1998, Pages 143-155

  Mphahlele, M Jeffrey ^a,c   Lau, George K K ^b   Carman, William F ^c  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Disease association; Epidemiology; GB virus C (GBV C); Hepatitis G virus (HGV); Prevalence

Indexed keywords

HEPATITIS ANTIBODY; INTERFERON; MARKER; RIBAVIRIN; VIRUS ENVELOPE PROTEIN;

ACUTE DISEASE; BLOOD DONOR; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; HEMODIALYSIS PATIENT; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HEPATITIS G VIRUS; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER; ORGAN TRANSPLANTATION; PERSISTENT INFECTION; PREVALENCE; REVIEW; RNA VIRUS; VIREMIA; VIRULENCE; VIRUS CLASSIFICATION; VIRUS DETECTION; VIRUS GENOME; VIRUS HEPATITIS; VIRUS REPLICATION;

EID: 0031847168     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00142.x     Document Type: Review

References (88)

1. SIMONS J N, LARY T P, DAWSON G J, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-9.
2. LINNEN J, WAGES JR J, ZHANG-KECK Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
3. DEINHARDT F, HOLMES A W, CAPPS R B, POPPER H. Studies on the transmission of human viral hepatitis to marmoset monkeys. Transmission of disease, serial passage and description of liver lesions. J Exp Med 1967; 125: 673-87.
4. SIMONS J N, PILOT-MATIAS, LEARY T P, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-5.
5. ZUCKERMAN A J. Alphabet of hepatitis viruses. Lancet 1996; 347: 558-9.
6. LEARY T P, MUERHOFF A S, SIMONS J N, et al. Sequence and genetic organisation of GBV-C: a novel member of the Flaviviridae associated with human non A-E hepatitis. J Med Virol 1996; 48: 60-7.
7. ERKER J C, SIMONS J N, MUERHOFF A S, et al. Nucleotide sequence of a GB virus C isolate from a patient with non A-E hepatitis. J Gen Virol 1996; 77: 2713-20.
8. LAU G, et al. (unpublished observations).
9. SHAO L, SHINZAWA H, ISHIKAWA K, et al. Sequence of hepatitis G virus genome isolated from a Japanese patient with non A-E hepatitis: amplification and cloning by long reverse transcription-PCR. Biochem Biophys Res Commun 1996; 228: 785-91.
10. SIMONS J N, DESAI S M, SCHULTZ D E, LEMON S M, MUSHAHWAR I K. Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organisation. J Virol 1996; 70: 6126-35.
11. HERINGLAKE S, OSTERKAMP S, TRAUTWEIN C, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-9.
12. MUERHOFF A S, SIMONS J N, LEARY T P, et al. Sequence heterogeneity in the 5′-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol 1996; 25: 379-84.
13. TSUDA F, HADIWANDOWO S, SAWADA N, et al. Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol 1996; 49: 248-52.
14. VIAZOF S, RIFFELMANN M, KHOUDYAKOV Y, FIELDS H, VARENHOLZ C, ROGENDORF M. Genetic heterogeneity of hepatitis G virus isolates from different parts of the world. J Gen Virol 1997; 78: 577-81.
15. KAO J H, CHEN P J, HSING S C, CHEN W, CHEN D S. Phylogenetic analysis of GB virus C: comparison of isolates from Africa, North America, and Taiwan. J Infect Dis 1996; 174: 410-3.
16. PICKERING J M, THOMAS H C, KARAYIANNIS P. Genetic diversity between hepatitis G isolates: analysis of nucleotide variation in the NS-3 and putative "core" peptide genes. J Gen Virol 1997; 78: 53-60.
17. WU R-R, MIZOKAMI M, CAO K, et al. GB virus C/hepatitis G virus infection in Southern China. J Infect Dis 1997; 175: 168-71.
18. FUKUSHI S, KURIHARA C, ISHIYAMA N, et al. Nucleotide sequence of the 5′ noncoding region of hepatitis G isolated from Japanese patients: comparison with reported isolates. Biochem Biophys Res Commun 1996; 226: 314-8.
19. GONZALEZ-PEREZ M A, NORDER H, BERGSTROM A, LOPEZ E, VISONA K A, MAGNIUS L O. High prevalence of GB virus C strains genetically related to strains of Asian origin in Nicaraguan haemophiliacs. J Med Virol 1997; 52: 149-55.
20. SMITH D B, CUCEANU N, DAVIDSON F, et al. Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5′ non-coding region. J Gen Virol 1997; 78: 1533-42.
21. TACKE M, KIYOSAWA K, STARK K, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-20.
22. DILLE B J, SROWY T K, GUTIERREZ R A, et al An ELISA for detection of antibodies to E2 protein of GB virus C. JID 1997; 175: 458-61.
23. KARAYIANNIS P, PICKERING J, CHIARAMONTE M, THOMAS H C. Hepatitis G virus infection. Lancet 1997; 349: 954.
24. SCHEICHER S, NORMANN A, GREGOR M, HESS G, FLEHMIG B. Hepatitis G virus infection. Lancet 1997; 349: 954-5.
25. GUTIERREZ R A, DAWSON G, KNIGGE M F, et al. Seroprevalence of GB virus C and persistence of RNA and antibody. J Med Virol 1997; 53: 167-73.
26. SCHLUETER V, SCHMOLKE S, STARK K, HESS G, OFENLOCH-HAENHNLE B, ENGEL A M. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol 1996; 34: 660-2664.
27. KAO J H, CHEN P J, CHEN W, HSIANG S C, LAI M Y, CHEN D S. Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome. J Med Virol 1997; 52: 284-9.
28. ZHANG X H, SHINZAWA H, SHAO L, et al. Detection of hepatitis G virus RNA in patients with hepatitis B, hepatitis C, and non A-E hepatitis by RT-PCR using multiple primer sets. J Med Virol 1997; 52: 385-90.
29. BHARDWAJ B, QIAN K, DETMER J, et al. Detection of GB virus-C/hepatitis G virus RNA in serum by reverse transcription polymerase chain reaction. J Med Virol 1997; 52: 92-6.
30. YOSHIBA M, OKAMOTO H, MISHIRO S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-2.
31. MASUKO K, MITSUI T, IWANO K. Infection with hepatitis GB virus C in patients on maintenance haemodialysis. N Engl J Med 1996; 334: 1485-90.
32. LEARY T P, MUERHOFF A S, SIMONS J N, et al. Consensus oligonucleotide primers for the detection of GB virus C in human cryptogenic hepatitis. J Virol Methods 1996; 56: 119-21.
33. MPHAHLELE M J, ASPINALL S, SPOONER R, CARMAN W F. Age-related prevalence of HGV in South Africans. Epidemiol Infect (submitted).
34. TUCKER T J, LOUW S J, ROBSON S C, ISAACS S, KIRSCH R. High prevalence of GBV-C hepatitis G virus infection in a rural South African population. J Med Virol 1997; 53: 225-8.
35. KINOSHITA T, MIYAKE K, NAKAO H, et al. Molecular investigation of GB virus C infection in haemophiliacs in Japan. J Infect Dis 1997; 175: 454-7.
36. WANG Y, CHEN H-S, FAN M-H, et al. Infection with GB virus C and hepatitis C virus in haemodialysis and blood donors in Beijing. J Med Virol 1997; 52: 26-30.
37. WANG H-L, JIN D-Y. Prevalence and genotype of hepatitis G virus in Chinese professional blood donors and hepatitis patients. J Infect Dis 1997; 175: 1229-33.
38. RAENGSAKULRACH B, ONG-AJ-YOOTH L, THAIPRASERT T, et al. High prevalence of hepatitis G viraemia among kidney transplant patients in Thailand. J Med Virol 1997; 53: 162-6.
39. BROWN K E, WONG S, BUU M, BINH T V, BE T V, YOUNG N S. High prevalence of GB virus C/hepatitis G virus in healthy persons in Ho Chi Minh City, Vietnam. J Infect Dis 1997; 175: 450-3.
40. SAIZ J C, AMPURDANES S, OLMEDO E, et al. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. J Hepatol 1997; 26: 787-93.
41. STARK K, BIENZLE U, HESS G, ENGEL A M, HEGENSCHEID B, SCHLUETER V. Detection of hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 120-1323.
42. KONDO Y, MIZOKAMI M, NAKANO T, et al. Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia. J Med Virol 1997; 52: 143-8.
43. DAWSON G J, SCHLUADER G G, PILOT-MATIAS T J, et al. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol 1996; 50: 97-103.
44. JARVIS L M, DAVIDSON F, HANLEY J R YAP P L, LUDLAN C A, SIMMONDS P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-5.
45. LIGHTFOOT K, SKELTON M, KEW M C, et al. Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans? Hepatology 1997; 26: 740-2.
46. KEW M C. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 1997; 38: S31-S6.
47. ELLIS L A, BROWN D, CONRADIE J D, et al. Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum. J Med Virol 1990; 32: 249-51.
48. BASETSE H R, PEENZA I, ASPINALL S. Hepatitis C virus antibodies in the black population of Ga-Rankuwa. Med Technol SA 1993; 6: 88-9.
49. SONI P N, TAIT D R, KENOYER D G, et al. Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 1993; 40: 65-8.
50. AIKAWA T, SUGAI Y, OKAMOTO H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334: 195-6.
51. LAMPE E, SABACK F L, YOSHIDA C F T, NIEL C. Infection with GB virus C/hepatitis G virus in Brazilian haemodialysis and hepatitis patients and asymptomatic individuals. J Med Virol 1997; 52. 61-7.
52. DE LAMBALLERIE X, CHARRELL R N, DUSSOL B. Hepatitis GB virus C in patients on haemodialysis. N Engl J Med 1996; 334: 1549.
53. SUGAI Y, NAKAYAMA H, FUKUDA M, et al. Infection with GB virus C in patients with chronic liver disease. J Med Virol 1997; 51: 175-81.
54. FRANCESCONI R, GIOSTRA F, BALLARDINI G. et al. Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis. J Hepatol 1997; 26: 1165-72.
55. SCHLEICHER S, CHAVES R L, DEHMER T, GREGO M, HESS G, FLEHMIG B. Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients. J Med Virol 1996; 50: 71-4.
56. YASHINA T L, FAVOROV M O, KHUDYAKOV Y E, et al. Detection of hepatitis G virus (HGV) RNA: clinical characteristics of acute HGV infection. J Infect Dis 1997; 175: 1302-7.
57. KUROKI T, NISHIGUCHI S, TANAKA M, ENOMOTO M, KOBAYASHI K. Does GBV-C cause fulminant hepatitis in Japan? Lancet 1996; 347: 908.
58. SALLIE R, SHAW J, MUTIMER D. GBV-C virus and fulminant hepatitic failure. Lancet 1996; 347: 68.
59. HAYDON G H, JARVIS L M, SIMPSON K J, HAYES P C, SIMMONDS P. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral, hepatitis. J Viral Hepat 1997; 4: 45-9.
60. LESNIEWSKI R, OKASINSKI G, CARRICK R, et al. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viraemia. J Med Virol 1995; 45: 415-22.
61. ROSS R S, VIAZOV S, SCHMITT U, et al. Distinct prevalence of antibodies to the E2 protein of GBV-C/hepatitis G virus in different parts of the world. J Med Virol 1998; 54: 103-6.
62. PILOT-MATIAS T, MUERHOFF A S, SIMONS J N, et al. Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B and GBV-C. J Med Virol 1996; 48: 329-38.
63. FEUCHT H-H, ZOLLNER B, POLYWKA S, et al. Distribution of hepatitis G viraemia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997; 26: 491-4.
64. SCHMIDT M, FLECKENSTEIN K K B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet 1996; 347: 909.
65. FEUCHT H-H, ZOLLNER B, POLYWKA S, LAUFS R. Vertical transmission of HGV. Lancet 1996; 347: 615-6.
66. FISCHLER B, LARA C, CHEN M, SONNERBORG A, NEMETH A, SALLBERG M. Genetic evidence for mother-to-baby transmission of hepatitis G virus. J Infect Dis 1997; 176: 281-5.
67. ZANETTI A R, TANZI E, ROMANO L, et al. Multicenter trial on mother-to-infant transmission of GBV-C virus. J Med Virol 1998; 54: 107-12.
68. CHEN M, SONNERBORG A, JOHANSSON B, SALLBERG M. Detection of hepatitis G virus (GB virus C) in human saliva. J Clin Microbiol 1997; 35: 973-5.
69. PERSICO T, THIERS V, TRIVERA R, DIFINE M, SEMPRINI A E, BRECHOT C. Detection of hepatitis G/GBV-C viral RNA but not HCV RNA in the different semen fractions of infected patients. Hepatology (AASLD abstract 399) 1996; 24: 226A.
70. KAO J H, CHEN W, CHEN P J, LAI M Y, LIN R Y, CHEN D S. GB virus-C/hepatitis G virus infection in prostitutes: possible role of sexual transmission. J Med Virol 1997b; 52: 381-4.
71. FIORDALISI G, BETTINARDI A, ZANELLA I, STELLENI R, PARANINFO G, CADEO GHPRIMI D. Parenteral and sexual exposure transmission of GB virus C and hepatitis C virus among human immuno-deficiency virus-positive patients. J Infect Dis 1997; 175: 1025-6.
72. NAKATSUJI Y, SHIH J W-K, TANAKA E, et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hepat 1996; 3: 307-16.
73. GOESER T, SEIPP S, WAHL R, MULLER H M, SREMMEL W, THEILMANN L. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C. J Hepatol 1997; 26: 498-502.
74. FRIED M W, KHUDYAKOV Y E, SMALLWOOD G A, et al. Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and non-viral chronic liver disease. Hepatology 1997; 25: 1271-5.
75. COTLER S, GRETCH D R, BRONNER M P, et al. Hepatitis G virus co-infection does not alter the course recurrent hepatitis C virus infection in liver transplantation recipients. Hepatology 1997; 26: 432-6.
76. PESSOA M, TERRAULT N A, FEREL L D, et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation, Hepatology 1997; 25: 1266-70.
77. KANDA T, YOKOSUKA O. EHATA, et al. Detection of GBV-C RNA in patients -with non A-E fulminant hepatitis by reverse transcription polymerase chain reaction. Hepatology 1997; 25: 1261-5.
78. MADEJON A, FOGEDA M, BARTOLOME J, et al. GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C and D. Gastroenterology 1997; 113: 573-8.
79. SAITO S, TANAKA K, KONDO M, et al. Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells. Biochem Biophys Res Commun 1997; 237: 288-91.
80. LASKUS T, WANG L-F, RADKOWSKI M, et al. Hepatitis G virus infection in American patients with cryptogenic cirrhosis: no evidence for liver replication. J Infect Dis 1997; 176: 1491-5.
81. TANAKA T, TAKEUCHI T, INOUE K, TANAKA S, KOHARA M. Acute hepatitis caused by sexual or household transmission of GBV-C. J Hepatol 1997; 27: 1110-2.
82. EGAWA K, YUKAWA T, ARAKAWA S, et al. Infection with GB virus C in leprous patients in Japan. J Med Virol 1996; 49: 110-4.
83. COLOMBATTO P, RANDONE A, CIVITICO G, et al. Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transferase and alkaline phosphatase: a specific liver disease? J Viral Hepat 1996; 3: 301-6.
84. TUCKER T J, SMUTS H E M, KIRSCH R E, et al. The hepatitis G virus/GBV-C is associated with glomerulonephritis. S Afr Med J 1998; 88: 285-6.
85. LAU J Y N, QIAN K P, DETMER J, et al. Effect of interferon a and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV. J Infect Dis 1997; 176: 421-6.
86. LOPEZ-ALCOROCHOJM, MILLAN A, GARCIA-TREVIJANO E R, et al. Detection of hepatitis GB virus type C RNA in serum and liver from children with chronic viral hepatitis B and C. Hepatology 1997; 25: 1258-60.
87. KAO J-H, CHEN P-J, WANG J-T, LAI M-Y, CHEN D-S. Blood bank screening for hepatitis G. Lancet 1997, 349: 207.
88. KIM J P, FRY K E. Molecular characterisation of the hepatitis G virus. J Viral Hepat 1997; 4: 77-9.